PARNAX LAB LTD. Share Price

₹ 107.00

-₹2.50 (-2.28%)
1D
Last updated 02 Nov, 2026, 14:29 IST
NSE: PARNAXLAB
|
Pharmaceuticals

PARNAX LAB LTD. Share Price Today

As of 2 Nov 2026, PARNAX LAB LTD. share price is ₹107.00. The stock opened at ₹109.50, compared to its previous close of ₹109.50. During today's trading session, PARNAX LAB LTD. share price moved in the range of ₹106.51 to ₹109.50, with an average price of ₹108.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹90.00 and a high of ₹149.50. On the performance front, PARNAX LAB LTD. share price has declined by 19.21% over the last six months and is down 19.21% on a year-on-year basis.

Share price over the last 1 day fell from 109.50 to 107.00, ranging between 106.51 and 109.50.

₹106.51
2.28% down today
₹109.50
1D LOW
1D HIGH

PARNAX LAB LTD. Stock Insights

Latest Earning
Op Profit TrendUp by 1.53% YoY
Latest Earning
Net Profit TrendUp by 2.25% YoY
Latest Earning
Revenue TrendUp by 33.21% YoY
Stock Performance
OutperformingBeat Nifty by 2.04 % in last 1 year
PARNAX LAB LTD. stock performance
Open₹109.50
High₹109.50
Low₹106.51
Prev. close₹109.50
PARNAX LAB LTD. trading activity
Volume30
Average traded price₹107.57
Last traded time02:29:00 02 Nov
Last traded quantity10

Circuit
L
H
₹87.60
₹131.40
52-week
L
H
₹90.00
₹149.50
Mkt Cap Cr
121.80

P/E
13.61

P/B
1.28

ROA
3.93%
ROE
12.38%

ROCE
12.15%

Quick Ratio
0.57

EV/EBITDA
7.78

Based on fundamentals, this stock's

Performance: 3 out of 5, Neutral
Performance
Neutral
Parnax Lab performance is moderate compared to markets
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Parnax Lab appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Parnax Lab earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

PARNAX LAB LTD. Company Background

ISIN
INE383L01019
Sector Market Cap
₹ 121.80 Cr

Parnax Lab Limited is an India-based holding company. The Company is principally engaged in the business activities of manufacturing and export of pharmaceutical formulations. The Company operates through the trading of the pharmaceuticals and medicinal products segment. It is engaged in developing and delivering huge volumes of oral formulations, such as cough expectorants, antacids, antihistamines, multi-vitamins, enzyme preparations, pediatric formulations, special formulations for geriatrics, viscous products, suspensions, and others. Its product portfolio consists of pharmaceuticals, cosmetics, herbal, and nutraceuticals. Its cosmetics products include antidruf gel, EVE fairness acne care night cream for acne skin, EVE fairness scrub, and others. The Company provides companies with the service of developing the drug through Contract Research and Manufacturing Services (C.R.A.M.S) or manufacturing collaborations. The Company’s subsidiary is Naxpar Pharma Private Limited.

PARNAX LAB LTD. Financial Highlights

  • Revenue: PARNAX LAB LTD. reported revenue of ₹252.32 crore in FY26 vs ₹189.42 crore in FY25. It showed an increase of 33.21% on a yearly basis.
  • Operating Profit: PARNAX LAB LTD. reported an operating profit of ₹15.91 crore in FY26 vs ₹15.67 crore in FY25. It showed an increase of 1.53% on a year-on-year basis.
  • Net Profit: PARNAX LAB LTD. reported a net profit of ₹11.80 crore in FY26 vs ₹11.54 crore in FY25. It showed an increase of 2.25% on a yearly basis.

PARNAX LAB LTD. Quarterly Result Highlights

  • PARNAX LAB LTD. reported revenue of ₹56.95 crore in Jun 2026, compared with ₹71.62 crore in Mar 2026, representing a decrease of 20.48% on a quarter-on-quarter (QoQ) basis.
  • PARNAX LAB LTD. reported an operating profit of ₹0.60 crore in Jun 2026, compared with ₹3.00 crore in Mar 2026, representing a decrease of 80.00% on a quarter-on-quarter (QoQ) basis.
  • PARNAX LAB LTD. reported a profit of ₹0.43 crore in Jun 2026, compared with ₹2.18 crore in Mar 2026, reflecting a decrease of 80.28% on a QoQ basis.
  • The earnings per share (EPS) of PARNAX LAB LTD. stood at ₹10.27 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
72.30%
FII
0.00%
Other DII
0.00%
Retail and other
27.70%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

PARNAX LAB LTD. Investment Returns

1 day
+0.03%

1 week
+5.80%

1 month
-2.00%

1 year
-19.21%

3 years
-19.21%

5 years
-19.21%

PARNAX LAB LTD. Share Price History

PARNAX LAB LTD. share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹113.96 / ₹109.50
+0.03%
29 Oct 26
₹105.29 / ₹109.47
+6.02%
28 Oct 26
₹105.79 / ₹103.25
-0.45%
27 Oct 26
₹105.39 / ₹103.72
+0.36%
Show more

PARNAX LAB LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹248.54₹187.74₹188.71₹167.61
Other Income₹3.78₹1.68₹0.82₹0.77
Total Revenue₹252.33₹189.41₹189.53₹168.38
Total Expenses₹235.05₹173.74₹177.48₹156.10
Profit Before Tax₹15.91₹15.67₹12.05₹12.28
Tax₹4.11₹4.14₹2.42₹3.65
Profit After Tax₹11.80₹11.54₹9.62₹8.63
EPS - Basic₹10.27₹10.05₹8.37₹7.80
EPS - Diluted₹10.27₹10.05₹8.37₹7.80

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹15.91₹15.67₹12.05₹12.28
Income before WC changes₹30.47₹28.51₹23.91₹23.86
Change in Assets-₹31.10₹8.14-₹13.07₹9.27
Change in Liabilities₹12.14-₹1.61₹7.67-₹9.35
Change in WC-₹18.95₹6.53-₹5.40-₹0.09
Cash flow from Operations₹8.00₹32.30₹15.88₹20.91
Cash flow from Investing-₹16.39-₹16.39-₹31.52-₹9.92
Cash flow from Financing₹8.18-₹15.82₹14.82-₹14.07
Total Cash Flow-₹0.21₹0.09-₹0.82-₹3.08
Cash (Start of the year)₹0.55₹0.46₹1.28₹4.36
Cash (End of the year)₹0.34₹0.55₹0.46₹1.28

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹136.94₹125.04₹116.95₹87.75
Current Assets₹90.69₹64.78₹73.31₹57.32
Total Assets₹227.63₹189.82₹190.26₹145.07
Current Liabilities₹95.85₹74.33₹83.33₹63.04
Net Current Asset-₹5.16-₹9.56-₹10.02-₹5.72
Non-Current Liabilities₹36.48₹32.24₹35.24₹19.77
Equity Capital₹95.30₹83.24₹71.69₹62.26
Total Equity & Liabilities₹227.63₹189.82₹190.26₹145.07

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹6.63₹7.02₹7.44₹7.47
Other Income₹2.37₹0.71₹0.54₹0.37
Total Revenue₹8.99₹7.73₹7.98₹7.84
Total Expenses₹8.31₹5.87₹5.53₹6.22
Profit Before Tax₹0.65₹1.86₹2.45₹1.63
Tax-₹0.24₹0.46₹0.62₹0.42
Profit After Tax₹0.89₹1.39₹1.82₹1.20
EPS - Basic₹0.77₹1.21₹1.59₹1.09
EPS - Diluted₹0.77₹1.21₹1.59₹1.09

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹0.65₹1.86₹2.45₹1.63
Income before WC changes₹1.35₹1.44₹2.34₹1.80
Change in Assets-₹1.30-₹1.81-₹2.35-₹1.34
Change in Liabilities-₹0.76₹0.68₹0.11-₹0.73
Change in WC-₹2.06-₹1.14-₹2.24-₹2.07
Cash flow from Operations-₹0.72₹0.28₹0.08-₹0.28
Cash flow from Investing₹0.57-₹0.19₹0.30₹0.14
Cash flow from Financing-₹0.03-₹0.02-₹1.21-₹2.92
Total Cash Flow-₹0.18₹0.06-₹0.83-₹3.07
Cash (Start of the year)₹0.50₹0.44₹1.27₹4.33
Cash (End of the year)₹0.32₹0.50₹0.44₹1.27

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹12.78₹14.02₹14.20₹14.87
Current Assets₹11.82₹10.69₹8.04₹6.50
Total Assets₹24.60₹24.72₹22.24₹21.37
Current Liabilities₹1.00₹1.74₹1.06₹1.84
Net Current Asset₹10.83₹8.96₹6.98₹4.65
Non-Current Liabilities₹0.19₹0.43₹0.02₹0.17
Equity Capital₹23.42₹22.54₹21.15₹19.35
Total Equity & Liabilities₹24.60₹24.72₹22.24₹21.37
* All values are in INR Crore
PARNAX LAB LTD. market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
PARNAX LAB LTD. technical summary
Bearish indicators3
Neutral indicators5
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
45.24
Neutral

ATR (14)
7.92
Neutral

STOCH(9,6)
65
Neutral

STOCH RSI (14)
100
Bearish

ADX(9)
36.13
Bearish

UO(9)
52.02
Neutral

ROC(12)
-3.68
Bearish

WillR(14)
-35
Neutral
Period
Simple value
Exponential vaue

5D
105.86
107.1

10D
106.27
107.2

20D
109.27
109.52

50D
119.22
109.47

100D
119.28
0
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
26 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

PARNAX LAB LTD.
Pharmaceuticals
Add Stock
Add Another

PARNAX LAB LTD. Returns Calculator

PARNAX LAB LTD. Share Price FAQs












Please be aware that PARNAX LAB LTD. stock prices are subject to continuous fluctuations due to various factors.